62
Participants
Start Date
August 3, 2021
Primary Completion Date
December 15, 2024
Study Completion Date
August 31, 2025
Continuous glucose monitoring device
Participants will have to wear their continuous glucose monitoring device throughout the study.
Gold method
The Gold method will be used to assess impaired awareness of hypoglycemia
Clarke questionnaire
The Clarke questionnaire will be used to assess impaired awarness of hypoglycemia
Edinburgh Hypoglycemia Symptom Scale
The Edinburgh Hypoglycemia Symptom Scale will be used to assess symptoms of hypoglycemia
BAPAD questionnaire
The BArriers to Physical Activity in type 1 Diabetes (BAPAD) questionnaire will be used to assess barriers of physical activity
Hypoglycemia Fear Survey II
The Hypoglycemia Fear Survey II will be used to assess fear of hypoglycemia
Physical activity questionnaire
The International Physical Activity Questionnaire will be used to assess physical activity practice
Well-being
The WHO-5 well-being index will be used to assess well-being.
Treatment satisfaction
The Diabetes Treatment Satisfaction Questionnaire will be used to assess treatment satisfaction.
Hypoglycemia diary
Participants will be asked to record in a diary treatments for hypoglycemic events
Piezo RxD
Participants will be asked to wear a pedometer throughout the study
Heart rate monitor
During training sessions, participants will be asked to wear a heart rate monitor
Exercise diary
Before each training session, participants will be asked to note in a diary their glucose levels, if they have taken a snack or not and if insulin was administered. After each training session, participants will be asked to note that same information. In addition, they will be asked to note their bedtime blood glucose, if they have taken a bedtime snack and if adjustment to insulin doses was made.
RECRUITING
Institut de recherches cliniques de Montréal, Montreal
Institut de Recherches Cliniques de Montreal
OTHER